Prognosis in colorectal cancer beyond TNM

Carethers, 2015, Genetics and genetic biomarkers in sporadic colorectal cancer, Gastroenterology., 149, 1177, 10.1053/j.gastro.2015.06.047 Kuipers, 2015, Colorectal cancer, Nat Rev Dis Primers, 1, 15065, 10.1038/nrdp.2015.65 Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin., 68, 394, 10.3322/caac.21492 Draht, 2018, Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review, Clin Epigenetics., 10, 35, 10.1186/s13148-018-0461-8 2018 Marmol, 2017, Colorectal carcinoma: a general overview and future perspectives in colorectal cancer, Int J Mol Sci., 18, 10.3390/ijms18010197 Marks, 2018, Clinicopathological, genomic and immunological factors in colorectal cancer prognosis, Br J Surg., 105, e99, 10.1002/bjs.10756 Gallois, 2016, Methylator phenotype in colorectal cancer: a prognostic factor or not?, Crit Rev Oncol Hematol., 99, 74, 10.1016/j.critrevonc.2015.11.001 Gelsomino, 2016, The evolving role of microsatellite instability in colorectal cancer: a review, Cancer Treat Rev., 51, 19, 10.1016/j.ctrv.2016.10.005 Seppala, 2015, Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer, Br J Cancer., 112, 1966, 10.1038/bjc.2015.160 Herzig, 2015, Molecular markers for colon diagnosis, prognosis and targeted therapy, J Surg Oncol., 111, 96, 10.1002/jso.23806 Setaffy, 2015, Microsatellite instability in colorectal cancer: clinicopathological significance, Pol J Pathol., 66, 203, 10.5114/pjp.2015.54953 Palomba, 2016, Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study, J Transl Med., 14, 292, 10.1186/s12967-016-1053-z Farooqi, 2019, Overview of the oncogenic signaling pathways in colorectal cancer: mechanistic insights, Semin Cancer Biol., 58, 65, 10.1016/j.semcancer.2019.01.001 Sinicrope, 2015, Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes, Gastroenterology., 148, 88, 10.1053/j.gastro.2014.09.041 Chang, 2017, Expending role of microsatellite instability in diagnosis and treatment of colorectal cancers, J Gastrointest Cancer., 48, 305, 10.1007/s12029-017-9991-0 Laporte, 2018, Clinical importance of DNA repair in sporadic colorectal cancer, Crit Rev Oncol Hematol., 126, 168, 10.1016/j.critrevonc.2018.03.017 Marginean, 2018, Is there a role for programmed death ligand-1 testing and immunotherapy in colorectal cancer with microsatellite instability? Part I-colorectal cancer: microsatellite instability, testing, and clinical implications, Arch Pathol Lab Med., 142, 17, 10.5858/arpa.2017-0040-RA Ghanipour, 2017, Associations of defect mismatch repair genes with prognosis and heredity in sporadic colorectal cancer, Eur J Surg Oncol., 43, 311, 10.1016/j.ejso.2016.10.013 Jia, 2017, Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer, Oncotarget., 8, 20198, 10.18632/oncotarget.15560 Fredericks, 2018, Beta-catenin regulation in sporadic colorectal carcinogenesis: not as simple as APC, Can J Gastroenterol Hepatol., 2018, 4379673, 10.1155/2018/4379673 Aguilera, 2015, Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer, Oncotarget., 6, 5903, 10.18632/oncotarget.3464 Takane, 2017, DNA methylation epigenotype and clinical features of NRAS-mutation(+) colorectal cancer, Cancer Med., 6, 1023, 10.1002/cam4.1061 Therkildsen, 2014, The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: a systematic review and meta-analysis, Acta Oncol., 53, 852, 10.3109/0284186X.2014.895036 Cohen, 2017, BRAF-mutated colorectal cancer: what is the optimal strategy for treatment?, Curr Treat Options Oncol., 18, 9, 10.1007/s11864-017-0453-5 Sepulveda, 2017, Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology, J Clin Oncol., 35, 1453, 10.1200/JCO.2016.71.9807 Nakaji, 2017, Prognostic value of BRAF V600E mutation and microsatellite instability in Japanese patients with sporadic colorectal cancer, J Cancer Res Clin Oncol., 143, 151, 10.1007/s00432-016-2275-4 Cohen, 2017, Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency, Eur J Cancer., 86, 266, 10.1016/j.ejca.2017.09.022 Carethers, 2016, Hereditary, sporadic and metastatic colorectal cancer are commonly driven by specific spectrums of defective DNA mismatch repair components, Trans Am Clin Climatol Assoc., 127, 81 Oh, 2016, Prognostic factors in sporadic colon cancer with high-level microsatellite instability, Surgery., 159, 1372, 10.1016/j.surg.2015.11.028 Scarpa, 2015, Mismatch repair gene defects in sporadic colorectal cancer enhance immune surveillance, Oncotarget., 6, 43472, 10.18632/oncotarget.6179 Otto, 2019, Microsatellite instability and manifestations of angiogenesis in stage IV of sporadic colorectal carcinoma, Medicine (Baltimore), 98, e13956, 10.1097/MD.0000000000013956 Ryan, 2017, The current value of determining the mismatch repair status of colorectal cancer: A rationale for routine testing, Crit Rev Oncol Hematol., 116, 38, 10.1016/j.critrevonc.2017.05.006 Alex, 2017, Response to chemotherapy and prognosis in metastatic colorectal cancer with DNA deficient mismatch repair, Clin Colorectal Cancer., 16, 228, 10.1016/j.clcc.2016.11.001 Copija, 2017, Clinical significance and prognostic relevance of microsatellite instability in sporadic colorectal cancer patients, Int J Mol Sci., 18, 10.3390/ijms18010107 Kubo, 2017, Mismatch repair protein deficiency is a risk factor for aberrant expression of HLA Class I molecules: a putative "adaptive immune escape" phenomenon, Anticancer Res., 37, 1289, 10.21873/anticanres.11446 Kim, 2016, Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers, Br J Cancer., 115, 490, 10.1038/bjc.2016.211 Lee, 2017, Prognostic implication of CD274 (PD-L1) protein expression in tumor-infiltrating immune cells for microsatellite unstable and stable colorectal cancer, Cancer Immunol Immunother., 66, 927, 10.1007/s00262-017-1999-6 Wrobel, 2019, Current status of immunotherapy in metastatic colorectal cancer, International journal of colorectal disease, 34, 13, 10.1007/s00384-018-3202-8 Chouhan, 2018, The interaction between BRAF mutation and microsatellite instability (MSI) status in determining survival outcomes after adjuvant 5FU based chemotherapy in stage III colon cancer, J Surg Oncol., 118, 1311, 10.1002/jso.25275